Prof. Dr. Shi-Hua Xiang received his BS in Biology from Hunan Normal University, MS in Mycology from Huazhong Agricultural University, and PhD in Microbiology from the University of Sydney. He did Postdoctoral training on HIV entry in Harvard Medical School and was also trained in Pfizer on drug development. Now, he is a Professor of the School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincon. He has received Grand Challenge Explorations (GCE) awards (Phase I and Phase II) from the Bill & Melinda Gates Foundation, His research has been focusing on antivirals by using innovative technologies to develop effective countermeasures against various viral pathogens including filoviruses (EBOV and MARV), flaviviruses (ZIKV, DENV and WNV) and retroviruses (HIV and OPPV). His research topics mainly include virology, vaccines, and drugs.